Dernières nouvelles

Information non disponible

17 enregistrements « 1 de 2 »

Nadler MB, Corrado AM, Desveaux L, Neil-Sztramko SE, Wilson BE, Desnoyers A, Amir E, Ivers N

Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40-49 years: a qualitative analysis

Article de revue

CMAJ Open, 10 (4), 2022.

Résumé | Liens:

Desnoyers A, Wilson BE, Nadler MB, Amir E

Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours

Article de revue

Cancer Treat Rev, 94 , 2021.

Résumé | Liens:

Jolivet C, Nassabein R, Soulières D, Weng X, Amireault C, Ayoub JP, Beauregard P, Blais N, Carrier C, Cloutier AS, Desnoyers A, Lemay AS, Lemay F, Loungnarath R, Jolivet J, Letendre F, Tehfé M, Vadnais C, Viens D, Aubin F

Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience

Article de revue

Oncologist, 26 (4), 2021.

Résumé | Liens:

Al-Showbaki L, Nadler MB, Desnoyers A, Almugbel FA, Cescon DW, Amir E

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

Article de revue

J Cancer, 12 (14), 2021.

Résumé | Liens:

Desnoyers A, Amir E, Tannock IF

Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?

Article de revue

JAMA Oncol, 7 (8), 2021.

| Liens:

Wilson BE, Desnoyers A, Nadler MB, Tibau A, Amir E

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations

Article de revue

Cancer Med, 10 (16), 2021.

Résumé | Liens:

Wilson BE, Nadler MB, Desnoyers A, Amir E

Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials

Article de revue

J Natl Compr Canc Netw, 19 (12), 2021.

Résumé | Liens:

Nadler MB, Ivers N, Marchand-Austin A, Lofters A, Austin PC, Wilson BE, Desnoyers A, Amir E

Patient and provider determinants of breast cancer screening among Ontario women aged 40-49: a population-based retrospective cohort study

Article de revue

Breast Cancer Res Treat, 189 (3), 2021.

Résumé | Liens:

Saleh RR, Nadler MB, Desnoyers A, Meti N, Fazelzad R, Amir E

Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis

Article de revue

Cancer Treat Rev, 100 , 2021.

Résumé | Liens:

Saleh RR, Nadler MB, Desnoyers A, Rodin DL, Abdel-Qadir H, Amir E

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

Article de revue

Sci Rep, 10 (1), 2020.

Résumé | Liens:

17 enregistrements « 1 de 2 »
Signaler des ajouts ou des modifications